InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Taubert Jennifer L, Directrice Exécutive. Officer active across 1 company, notably Johnson & Johnson. In total, 14 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €3.4m. History available since 14 February 2022. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Taubert Jennifer L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
15,000 股@ US$115.670.0003% mcap6.2% 占其流量Common StockSEC:0000200406-26-000175:0
15,000 股@ US$263.360.0006% mcap14.0% 占其流量Common StockSEC:0000200406-26-000175:1
1,302 股0Common StockSEC:0000200406-26-000037:0
56,471 股@ US$101.8730.8% 占其流量Common StockSEC:0000200406-25-000186:0
1,302 股0Common StockSEC:0000200406-25-000052:0
58,504 股@ US$100.0650.9% 占其流量Common StockSEC:0000200406-25-000013:0
1,302 股0Common StockSEC:0001225208-24-002181:0
22,433 股0Common StockSEC:0001225208-24-002103:0
3,739 股0Common StockSEC:0001225208-24-001900:0
21,422 股0Common StockSEC:0001225208-23-002065:0
3,570 股0Common StockSEC:0001225208-23-001907:0
76,923 股@ US$72.5449.1% 占其流量Common StockSEC:0001225208-22-011890:0
18,064 股0Common StockSEC:0001225208-22-002377:0
3,297 股0Common StockSEC:0001225208-22-002211:0
14 条申报中的 14 条
About Taubert Jennifer L
Taubert Jennifer L is Directrice Exécutive and EVP, WWC. Innovative Medicine at Johnson & Johnson (XNAS). She has 12 filings in total, and across the 12 sampled filings the buy and sell amounts are both EUR 0, over the period from 2022-02-15 to 2026-02-18. The most frequent transaction nature is option exercise.
